Artificial Pancreas Device Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Artificial Pancreas Device Systems Market: By Technology (Threshold Suspended Device Systems, Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT)) , By End User (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres), By Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Artificial Pancreas Device Systems Market was valued at USD 97 million in 2021 and poised to reach USD 221.2 million by 2028 growing at a CAGR of 12.5% during the forecast period 2022 to 2028. Artificial pancreas device systems are medical devices which links glucose to an insulin infusion pump, monitor reading. These devices are meant to improve glycaemic control in patients with insulin-dependent diabetes and in control of nocturnal hypoglycaemia. The pancreas will secrete insulin and glucagon. Type-I diabetes occurs when the pancreas produces little or none of the insulin needed to regulate blood glucose. Type-II diabetes occurs when the pancreas does not produce enough insulin or the body becomes resistant to insulin that is present. The burgeoning incidence of diabetes is the major factor, which is expected to trigger the artificial pancreas devices market. As per WHO, global diabetes cases were increased from 108 Mn to 422Mn from 1980 to 2014. As per, Juvenile Diabetes Research Foundation in 2015, around 1.5Mn cases of type-I were found. Furthermore, growing geriatric population, increase in the incidence of lifestyle disorders and obesity which further leads diabetes which in turns propel the growth of artificial pancreas devices market. However, the insulin used in artificial pancreas devices takes the long duration to get absorb, lack of awareness, a dearth of skilled professionals are the factors which are restraining the growth of Artificial Pancreas Device Systems Market. Favourable regulations, increased collaborations coupled with rising prevalence of diabetes are expected to boost the market. FDA is collaborating with government and private research institutions to enhance the clinical studies and to speed up the development of innovative technologies in artificial pancreas device systems. In 2012 October, FDA has released a document of requirements needed for the clinical studies and premarket approval applications for the production of artificial pancreas device systems. Juvenile diabetes research foundation (JDRF) funds for the type 1 DM research in order to commercialize first artificial pancreas in 2017.

Artificial Pancreas Device Systems Market

MARKET SUMMARY
-
12.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Artificial Pancreas Device Systems Market

  • The global Artificial Pancreas Device Systems Market report gives comprehensive outlook on Artificial Pancreas Device Systems Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Artificial Pancreas Device Systems Market gives historical, current, and future market sizes (US$ Mn) on the basis of technology, end user, application and Region.
Key Players
  • MEDIUM TECHNOLOGIES (UK)
  • Medtronic (U.S)
  • Tandem Diabetes Care, Inc. (U.S)
  • Beta Bionics (U.S)
  • Johnson & Johnson (U.S)
Dynamics

Artificial Pancreas Device Systems Market

Technological innovations and product developments are propelling the market growth such as Tandem diabetes care outline its plans in APDS market by initiating R&D phase of its artificial pancreas system. Bigfoot Biomedical’s goal is to create a pump sensor union therapy which could be much simpler than the current counterparts. Beta bionics developed iLet Bionic Pancreas System which delivers both insulin and glucagon in type-1DM patients. Hence, all these products from the major players will be available soon which could increase the growth of the market.


North-America got significant share

Artificial Pancreas Device Systems Market

Artificial Pancreas Device Systems Market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. North America is expected to be a leader in artificial pancreas device systems market owing to high disposable income, growing prevalence of type 1DM, the high adaptation of technological advancements and favourable reimbursement policies. As per, Centre for diseases control and Prevention (CDC), type 1 DM accounts for around 5% of total diagnosed adults with diabetes cases in U.S. Europe artificial pancreas device system market is witnessed significant growth due to faster regulatory approvals and robust clinical trial pipeline. For example, AP@Home is a project initiated by the European Union and completed in 2015, which was focussed on the development of the combined device capable of administering insulin and monitoring glucose levels of the patient with the help of the single catheter. Asia Pacific artificial pancreas devices market is anticipated to offer lucrative opportunities due to high prevalence and incidence of diabetes, large population pool, and change in lifestyle of the people etc.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Artificial Pancreas Device Systems Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive Summary
  2. Global Artificial Pancreas Device Systems Market Introduction
    • Global Artificial Pancreas Device Systems Market – Taxonomy
    • Global Artificial Pancreas Device Systems Market –Definitions
      • Technology
      • End User
      • Application
  1. Global Artificial Pancreas Device Systems Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Artificial Pancreas Device Systems Market Dynamic Factors – Impact Analysis
    • Global Artificial Pancreas Device Systems Market – Competition Landscape
    • Epidemiology
  2. Global Artificial Pancreas Device Systems Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Artificial Pancreas Device Systems Market, By Technology, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Threshold Suspended Device Systems
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Treat to Range/Control to Range (TTR/CTR)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Treat to Target/ Control to Target (TTR/CTT)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Artificial Pancreas Device Systems Market Forecast, By End User,2013 – 2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic centres
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory surgical centres
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Artificial Pancreas Device Systems Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type 1 Diabetic Patients
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type 2 Diabetic Patients
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Artificial Pancreas Device Systems Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Region, 2018 – 2024
  2. North America Artificial Pancreas Device Systems Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Threshold Suspended Device Systems
      • Treat to Range/Control to Range (TTR/CTR)
      • Treat to Target/ Control to Target (TTR/CTT)
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic centres
      • Ambulatory surgical centres
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1 Diabetic Patients
      • Type 2 Diabetic Patients
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Country, 2018 – 2024
    • North America Artificial Pancreas Device Systems Market Dynamics – Trends
  3. Europe Artificial Pancreas Device Systems Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Threshold Suspended Device Systems
      • Treat to Range/Control to Range (TTR/CTR)
      • Treat to Target/ Control to Target (TTR/CTT)
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic centres
      • Ambulatory surgical centres
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1 Diabetic Patients
      • Type 2 Diabetic Patients
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Country,2018 – 2024
    • Europe Artificial Pancreas Device Systems Market Dynamics – Trends
  4. Asia-Pacific Artificial Pancreas Device Systems Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Threshold Suspended Device Systems
      • Treat to Range/Control to Range (TTR/CTR)
      • Treat to Target/ Control to Target (TTR/CTT)
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic centres
      • Ambulatory surgical centres
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1 Diabetic Patients
      • Type 2 Diabetic Patients
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Country,2018 – 2024
    • Asia-Pacific Artificial Pancreas Device Systems Market Dynamics – Trends
  5. Latin America Artificial Pancreas Device Systems Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Threshold Suspended Device Systems
      • Treat to Range/Control to Range (TTR/CTR)
      • Treat to Target/ Control to Target (TTR/CTT)
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic centres
      • Ambulatory surgical centres
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1 Diabetic Patients
      • Type 2 Diabetic Patients
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Country,2018 – 2024
    • Latin America Artificial Pancreas Device Systems Market Dynamics – Trends
  6. Middle East and Africa Artificial Pancreas Device Systems Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Threshold Suspended Device Systems
      • Treat to Range/Control to Range (TTR/CTR)
      • Treat to Target/ Control to Target (TTR/CTT)
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic centres
      • Ambulatory surgical centres
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1 Diabetic Patients
      • Type 2 Diabetic Patients
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Artificial Pancreas Device Systems Market – Opportunity Analysis Index, By Technology, By End User, By Application and Country,2018 – 2024
    • MEA Artificial Pancreas Device Systems Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Technology& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • MEDIUM TECHNOLOGIES (UK)
      • Medtronic (U.S)
      • Tandem Diabetes Care, Inc. (U.S)
      • Beta Bionics (U.S)
      • Johnson & Johnson (U.S)
      • Insulet Corporation (U.S)
      • Bigfoot Biomedical, INC.(U.S).
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • MEDTRUM TECHNOLOGIES (UK)
  • Medtronic (U.S)
  • Tandem Diabetes Care, Inc. (U.S)
  • Beta Bionics (U.S)
  • Johnson & Johnson (U.S)
  • Insulet Corporation (U.S)
  • Bigfoot Biomedical, INC.(U.S).

Description

Artificial Pancreas Device Systems Market was valued at USD 97 million in 2021 and poised to reach USD 221.2 million by 2028 growing at a CAGR of 12.5% during the forecast period 2022 to 2028. Artificial pancreas device systems are medical devices which links glucose to an insulin infusion pump, monitor reading. These devices are meant to improve glycaemic control in patients with insulin-dependent diabetes and in control of nocturnal hypoglycaemia. The pancreas will secrete insulin and glucagon. Type-I diabetes occurs when the pancreas produces little or none of the insulin needed to regulate blood glucose. Type-II diabetes occurs when the pancreas does not produce enough insulin or the body becomes resistant to insulin that is present. The burgeoning incidence of diabetes is the major factor, which is expected to trigger the artificial pancreas devices market. As per WHO, global diabetes cases were increased from 108 Mn to 422Mn from 1980 to 2014. As per, Juvenile Diabetes Research Foundation in 2015, around 1.5Mn cases of type-I were found. Furthermore, growing geriatric population, increase in the incidence of lifestyle disorders and obesity which further leads diabetes which in turns propel the growth of artificial pancreas devices market. However, the insulin used in artificial pancreas devices takes the long duration to get absorb, lack of awareness, a dearth of skilled professionals are the factors which are restraining the growth of Artificial Pancreas Device Systems Market. Favourable regulations, increased collaborations coupled with rising prevalence of diabetes are expected to boost the market. FDA is collaborating with government and private research institutions to enhance the clinical studies and to speed up the development of innovative technologies in artificial pancreas device systems. In 2012 October, FDA has released a document of requirements needed for the clinical studies and premarket approval applications for the production of artificial pancreas device systems. Juvenile diabetes research foundation (JDRF) funds for the type 1 DM research in order to commercialize first artificial pancreas in 2017.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX